Comparison of Dapagliflozin, Lobeglitazone, and Its Combination in Efficacy and Safety
Condition:   Diabetes Type 2 Interventions:   Drug: Dapagliflozin 10mg Tab;   Drug: Lobeglitazone 0.5 mg;   Drug: Dapagliflozin + Lobeglitazone Sponsor:   Seoul National University Bundang Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 23, 2023 Category: Research Source Type: clinical trials

Efficacy and Safety of LID104 in the Treatment of Type II Diabetes Mellitus
Condition:   Type 2 Diabetes Mellitus Interventions:   Drug: LID104;   Drug: Dapagliflozin;   Drug: Linagliptin Sponsor:   EMS Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 2, 2023 Category: Research Source Type: clinical trials